Anti-Müllerian Hormone Expression in Endometrial Cancer Tissue.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Mar 2019
Historique:
received: 24 01 2019
revised: 11 03 2019
accepted: 12 03 2019
entrez: 20 3 2019
pubmed: 20 3 2019
medline: 6 7 2019
Statut: epublish

Résumé

Anti-Müllerian hormone (AMH) is a commonly known factor secreted by Sertoli cells, responsible for regression of the Müllerian ducts in male fetuses. AMH has also other functions in humans. In vivo and in vitro studies have shown that AMH inhibits cell cycle and induces apoptosis in cancers with AMH receptors. The aim of the study was to assess whether the tissue of pre-cancerous states of endometrium (PCS) and various histopathologic types of endometrial cancer (EC) exhibit the presence of AMH. We aimed to investigate whether the potential presence of the protein concerns menopausal women or those regularly menstruating, and whether is related to cancers with a good or a bad prognosis, as well as what other factors may influence AMH expression. The undertaken analysis was carried out on tissues retrieved from 232 women who underwent surgical treatment for PCS and EC. Tissues were prepared for immunohistochemical assessment with the use of a tissue microarrays method. AMH expression was confirmed in 23 patients with well differentiated endometrioid adenocarcinoma (G1), moderately differentiated endometrioid adenocarcinoma (G2), clear cell carcinoma (CCA) and nonatypical hyperplasia. AMH was not found in EC tissues in regularly menstruating women. An appropriately long mean period of breastfeeding in line with a prolonged period of hormonal activity had a positive effect on AMH expression. Our results may suggest that AMH is a factor which protects the organism against cancer, and should be further investigated as a potential prognosis marker and a therapeutic agent.

Identifiants

pubmed: 30884769
pii: ijms20061325
doi: 10.3390/ijms20061325
pmc: PMC6471522
pii:
doi:

Substances chimiques

Anti-Mullerian Hormone 80497-65-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : University of Warmia and Mazury in Olsztyn
ID : 61.610.001-300

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Gynecol Oncol. 1999 Apr;73(1):51-5
pubmed: 10094880
J Clin Endocrinol Metab. 1999 Oct;84(10):3836-44
pubmed: 10523039
Clin Cancer Res. 1999 Nov;5(11):3488-99
pubmed: 10589763
Fertil Steril. 2000 Apr;73(4):859-61
pubmed: 10731554
J Biol Chem. 2000 Sep 15;275(37):28371-9
pubmed: 10874041
J Biol Chem. 2000 Oct 13;275(41):32066-70
pubmed: 10906337
J Biol Chem. 2000 Nov 24;275(47):37101-9
pubmed: 10958795
Hum Pathol. 2000 Oct;31(10):1202-8
pubmed: 11070112
N Engl J Med. 2001 Mar 15;344(11):783-92
pubmed: 11248153
J Biol Chem. 2001 Jul 20;276(29):26799-806
pubmed: 11356848
Cell Res. 2001 Jun;11(2):89-94
pubmed: 11453551
Histochem Cell Biol. 2001 Jun;115(6):489-97
pubmed: 11455449
Endocr Rev. 2001 Oct;22(5):657-74
pubmed: 11588147
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):239-44
pubmed: 11773638
Fertil Steril. 2002 Feb;77(2):357-62
pubmed: 11821097
Endocrinology. 2002 Mar;143(3):1076-84
pubmed: 11861535
Endocrinology. 2002 Sep;143(9):3351-60
pubmed: 12193547
Cancer Res. 2002 Oct 15;62(20):5920-9
pubmed: 12384558
Genes Cells. 2002 Dec;7(12):1191-204
pubmed: 12485160
Lancet. 2003 May 24;361(9371):1810-2
pubmed: 12781553
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9348-53
pubmed: 12878721
Mol Cell Endocrinol. 2003 Dec 15;211(1-2):9-14
pubmed: 14656470
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15601-6
pubmed: 14671316
Gynecol Oncol. 2004 May;93(2):499-505
pubmed: 15099969
J Clin Endocrinol Metab. 1992 Sep;75(3):911-7
pubmed: 1517385
Obstet Gynecol Clin North Am. 2004 Dec;31(4):837-56, x-xi
pubmed: 15550338
Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):111-6
pubmed: 15618407
Gynecol Oncol. 2005 May;97(2):431-5
pubmed: 15863141
J Soc Gynecol Investig. 2005 Oct;12(7):545-8
pubmed: 16046154
J Med Genet. 2006 Jun;43(6):531-3
pubmed: 16258005
Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16421-5
pubmed: 16260730
Nature. 2006 Feb 16;439(7078):871-4
pubmed: 16357870
Reproduction. 2006 Jan;131(1):1-9
pubmed: 16388003
Clin Cancer Res. 2006 Mar 1;12(5):1593-8
pubmed: 16533786
FEBS Lett. 2006 May 22;580(12):2811-20
pubmed: 16678165
Hum Reprod. 2006 Aug;21(8):2022-6
pubmed: 16679324
Development. 2006 Jun;133(12):2359-69
pubmed: 16687449
Clin Endocrinol (Oxf). 2006 Jun;64(6):603-10
pubmed: 16712660
J Clin Oncol. 2006 Oct 10;24(29):4783-91
pubmed: 17028294
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17426-31
pubmed: 17088539
Nat Rev Cancer. 2006 Dec;6(12):909-23
pubmed: 17128209
Hum Mol Genet. 2007 Jan 15;16(2):154-64
pubmed: 17164260
N Engl J Med. 2006 Dec 28;355(26):2733-43
pubmed: 17192538
Cell. 2007 Feb 23;128(4):735-45
pubmed: 17320510
N Engl J Med. 1992 Feb 13;326(7):466-71
pubmed: 1732773
Gynecol Oncol. 2007 Oct;107(1):71-4
pubmed: 17599395
Reproduction. 2007 Aug;134(2):209-21
pubmed: 17660231
Development. 1991 Oct;113(2):613-24
pubmed: 1782869
Endocrinology. 2008 Jan;149(1):108-15
pubmed: 17947357
Endocr Relat Cancer. 2008 Mar;15(1):59-72
pubmed: 18310276
Fertil Steril. 2009 Apr;91(4):1195-203
pubmed: 18328480
Expert Rev Anticancer Ther. 2008 Jul;8(7):1159-67
pubmed: 18588460
Proc Soc Exp Biol Med. 1947 Nov;66(2):302
pubmed: 18921738
Dev Biol. 2009 Jan 15;325(2):351-62
pubmed: 19013450
Gynecol Oncol. 2009 Jul;114(1):57-60
pubmed: 19359032
Hum Reprod. 2009 Sep;24(9):2264-75
pubmed: 19520713
Int J Gynecol Cancer. 2009 Jul;19(5):847-55
pubmed: 19574772
Future Oncol. 2010 Mar;6(3):391-405
pubmed: 20222796
Food Chem Toxicol. 2011 Aug;49(8):1737-44
pubmed: 21554918
PLoS One. 2011;6(5):e20087
pubmed: 21637711
PLoS One. 2011;6(7):e22024
pubmed: 21789206
Lab Invest. 2011 Nov;91(11):1605-14
pubmed: 21808236
Biochem Med (Zagreb). 2011;21(3):219-30
pubmed: 22420235
J Clin Endocrinol Metab. 2012 Sep;97(9):3224-30
pubmed: 22761458
J Clin Endocrinol Metab. 1990 Jan;70(1):16-22
pubmed: 2294129
Cell Biochem Biophys. 2013 Jul;66(3):567-87
pubmed: 23300026
Nature. 2013 May 2;497(7447):67-73
pubmed: 23636398
Eur J Cancer. 2015 Jun;51(9):1164-87
pubmed: 24120180
Proc Natl Acad Sci U S A. 1986 Aug;83(15):5464-8
pubmed: 2426698
Am J Obstet Gynecol. 2014 Jul;211(1):59.e1-8
pubmed: 24593938
Hum Reprod Update. 2014 Sep-Oct;20(5):688-701
pubmed: 24821925
Lancet Oncol. 2014 Jun;15(7):e268-78
pubmed: 24872110
J Obstet Gynaecol. 2015 Feb;35(2):178-82
pubmed: 25111828
Obstet Gynecol Sci. 2014 Sep;57(5):343-57
pubmed: 25264524
Int J Oncol. 2015 Mar;46(3):933-43
pubmed: 25573346
Fertil Steril. 2015 Apr;103(4):1074-1080.e4
pubmed: 25681853
Int J Oncol. 2015 May;46(5):2039-46
pubmed: 25760378
Nat Rev Mol Cell Biol. 2015 Nov;16(11):643-649
pubmed: 26420232
Int J Surg Pathol. 2016 May;24(3):269-73
pubmed: 26621753
Nat Commun. 2016 Jan 12;7:10055
pubmed: 26753790
Biomed Rep. 2016 Mar;4(3):275-281
pubmed: 26998263
Med Sci Monit. 2016 Sep 08;22:3186-90
pubmed: 27604213
Mol Cell Endocrinol. 2017 Jan 5;439:363-368
pubmed: 27664518
Int J Pediatr Endocrinol. 2016;2016:20
pubmed: 27799946
Fertil Steril. 2017 Feb;107(2):387-396.e4
pubmed: 27912901
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
J Assist Reprod Genet. 2017 Sep;34(9):1105-1113
pubmed: 28643088
Br J Cancer. 2017 Oct 24;117(9):1412-1418
pubmed: 28873086
Clin Chim Acta. 2018 Jan;476:123-129
pubmed: 29175649
Expert Rev Proteomics. 2018 Jan;15(1):81-99
pubmed: 29183259
Maturitas. 2018 Mar;109:112-117
pubmed: 29292013
Acta Obstet Gynecol Scand. 2018 Sep;97(9):1105-1113
pubmed: 29476703
Medicine (Baltimore). 2018 Jan;97(2):e9554
pubmed: 29480845
Cell Rep. 2018 Feb 27;22(9):2469-2481
pubmed: 29490281
Biomed Pharmacother. 2018 Jul;103:336-345
pubmed: 29665555
Eur J Cancer Prev. 2019 May;28(3):196-202
pubmed: 29672353
Asian Pac J Cancer Prev. 2018 Apr 25;19(4):969-975
pubmed: 29693365
Oncol Lett. 2018 Jun;15(6):9429-9435
pubmed: 29805666
Arch Gynecol Obstet. 2018 Nov;298(5):1029-1035
pubmed: 30242498
Cytogenet Cell Genet. 1987;44(1):2-6
pubmed: 3028714
Adv Ther. 2018 Nov;35(11):1805-1815
pubmed: 30311070
Pathologe. 1987 May;8(3):138-40
pubmed: 3303008
Cell. 1986 Jun 6;45(5):685-98
pubmed: 3754790
Science. 1981 Mar 20;211(4488):1278-84
pubmed: 7010602
Endocrinology. 1995 Dec;136(12):5614-22
pubmed: 7588316
Mol Endocrinol. 1994 Aug;8(8):1006-20
pubmed: 7997230
Early Hum Dev. 1993 Jun;33(2):91-9
pubmed: 8055780
J Pediatr Surg. 1993 Mar;28(3):439-44
pubmed: 8468660
Mol Cell Biol. 1996 May;16(5):2445-52
pubmed: 8628312
Int J Cancer. 1997 May 2;71(3):360-3
pubmed: 9139868
N Engl J Med. 1997 May 22;336(21):1480-6
pubmed: 9154766
Am J Epidemiol. 1998 Aug 1;148(3):234-40
pubmed: 9690359
Science. 1998 Aug 14;281(5379):998-1001
pubmed: 9703517
Hum Pathol. 1998 Aug;29(8):840-5
pubmed: 9712426
Science. 1998 Dec 18;282(5397):2270-2
pubmed: 9856953

Auteurs

Marek Gowkielewicz (M)

Department of Gynecology and Obstetrics, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-045 Olsztyn, Poland. marekgowkielewicz@gmail.com.

Aleksandra Lipka (A)

Department of Gynecology and Obstetrics, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-045 Olsztyn, Poland. aleksandra.lipka@uwm.edu.pl.

Aleksandra Piotrowska (A)

Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland. aleksandra.piotrowska@umed.wroc.pl.

Marta Szadurska-Noga (M)

Department of Pathomorphology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-561 Olsztyn, Poland. szadurskamarta@gmail.com.

Jacek J Nowakowski (JJ)

Department of Ecology & Environmental Protection, University of Warmia and Mazury in Olsztyn, 10⁻727 Olsztyn, Poland. jacek.nowakowski@uwm.edu.pl.

Piotr Dzięgiel (P)

Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland. piotr.dziegiel@umed.wroc.pl.
Department of Physiotherapy, Wroclaw University School of Physical Education, 51-612 Wroclaw, Poland. piotr.dziegiel@umed.wroc.pl.

Mariusz Krzysztof Majewski (MK)

Department of Human Physiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland. mariusz.majewski@uwm.edu.pl.

Marcin Jozwik (M)

Department of Gynecology and Obstetrics, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-045 Olsztyn, Poland. prof.jozwik@gmail.com.

Marta Majewska (M)

Department of Human Physiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Poland. marta.majewska@uwm.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH